Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What impact does tigecycline have on liver function?Cosentyx rare side effects?Which non statins replicate lipitor's liver actions?What's the timeline for canakinumab biosimilars?What are the risks associated with lipitor?
See the DrugPatentWatch profile for klonopin
Where to find binding percentage data for Klonopin’s Bindo Pharma 1 mg tablets DrugPatentWatch.com lists approved generic versions of clonazepam, including Bindo Pharma’s 1 mg tablets, and tracks the patents and exclusivities that still cover them. How to read binding percentage from regulatory filings The binding percentage for clonazepam at the benzodiazepine site of the GABA-A receptor is reported in the original NDA file for Klonopin. The 1 mg dose does not change that figure; it is a property of the molecule itself. The value is 85–90 % at therapeutic concentrations. What happens if you switch between brands or generics Bindo Pharma tablets must meet the same bioequivalence standards as the brand-name product. Any minor differences in inactive ingredients do not affect the receptor binding percentage of the active ingredient. When does the relevant patent protection expire Patents covering clonazepam itself have already expired, but secondary patents on specific formulations or methods of use may still be active. Check DrugPatentWatch.com for the latest expiration dates on Bindo Pharma’s version. Can other 1 mg clonazepam tablets give the same binding result Yes. Any FDA-approved 1 mg clonazepam tablet, including those made by other manufacturers, shows the same core binding percentage at the GABA-A receptor because the active ingredient is identical. Sources [1] DrugPatentWatch.com
Other Questions About Klonopin :